Call Toll-free: 1-888-333-93-63 (9:00 am - 5:00 pm ET)

Buy Compazine (Prochlorperazine 5mg) Online - Phenothiazine Dopamine D2 Antagonist for Severe Nausea Vomiting Vertigo

Brand name:
Compazine
Generic name:
Prochlorperazine
Buy Generic Compazine (Prochlorperazine) 5 mg Online
Actual product may differ in appearance from image shown.

Compazine (Prochlorperazine 5mg) represents the classic phenothiazine antiemetic that established D2 dopamine receptor antagonism as effective therapy for severe nausea and vomiting — the medication providing rapid relief since SmithKline & French Laboratories (later GlaxoSmithKline) received original FDA approval in 1956. Manufactured by Abbott India as bioequivalent generic, Compazine offers proven antiemetic efficacy across chemotherapy-induced nausea, post-surgical vomiting, severe migraine-associated nausea, vertigo, and gastroenteritis. As a first-generation phenothiazine, prochlorperazine remains valuable when newer 5-HT3 antagonists (ondansetron) are ineffective or when dual-mechanism therapy is beneficial for severe refractory nausea.

Prochlorperazine works through selective dopamine D2 receptor antagonism at the chemoreceptor trigger zone (CTZ) in the area postrema of the medulla — the primary brain region that initiates the vomiting reflex. Additional mechanisms include D2 antagonism in mesolimbic pathway providing antipsychotic effects, H1 histamine receptor blockade contributing to sedation and vestibular symptom relief, alpha-1 adrenergic blockade, and muscarinic anticholinergic effects. This multi-receptor profile produces rapid nausea suppression, reduced vomiting episodes, relief of vertigo symptoms, calming effect for agitation, and antipsychotic action when required. Clinical response: nausea and vomiting suppression within 30-60 minutes of dosing, peak effect at 2 hours, and consistent 3-4 hour antiemetic control supporting TID-QID dosing.

Compazine serves multiple severe nausea and psychiatric indications. Primary uses include severe nausea and vomiting from any cause including chemotherapy, radiation therapy, and post-surgical emesis; chemotherapy-induced nausea as second-line therapy or in combination with 5-HT3 antagonists; post-surgical nausea and vomiting prevention and treatment; severe migraine-associated nausea as adjunctive therapy; vertigo from vestibular disorders including Ménière disease; schizophrenia and acute psychotic episodes as antipsychotic therapy; short-term non-psychotic anxiety in select cases; and gastroenteritis-related severe vomiting requiring prescription antiemetic therapy.

Compazine requires 3-4 times daily dosing (typical 5-10 mg TID/QID for antiemetic use, higher doses for psychiatric indications). Peak concentrations at 2 hours, 6-8 hour half-life. Monitor for extrapyramidal side effects particularly at higher doses. Abbott India manufactures under WHO-GMP standards.

Order Compazine (Prochlorperazine 5 mg)

Dosage:5 mg
Quantity (max. 3) Package Price, USD You save
x1 90 tabs $60.00 $69.53You save ($9.53) $9.53
x1 180 tabs(bestseller) $100.00 $145.63You save ($45.63) $45.63
Price: $100.00
To see your bonus tabs, please sign in.

Free prescription

Our doctor prescribes Prochlorperazine online for free, and there is no doctor’s consultation fee.

Discrete packaging

All orders of Prochlorperazine arrive in discrete unmarked parcels. We leave the shipment description blank.

Have questions?

See our FAQ
Prochlorperazine Maleate 5mg — chemical formula C20H24ClN3S — represents the classic phenothiazine antiemetic and antipsychotic, developed by SmithKline & French Laboratories and FDA-approved as Compazine in 1956. As a first-generation phenothiazine dopamine D2 receptor antagonist, prochlorperazine works at the chemoreceptor trigger zone (CTZ) in the area postrema suppressing the vomiting reflex, with additional D2 blockade in mesolimbic pathway providing antipsychotic effects. The compound demonstrates rapid nausea and vomiting suppression within 30-60 minutes, consistent 3-4 hour antiemetic control, relief of vertigo symptoms, and calming antipsychotic action for acute psychiatric episodes. Available as 5 mg oral tablets requiring 3-4 times daily dosing for antiemetic use, prochlorperazine shows peak blood levels at 2 hours and 6-8 hour half-life. Monitor for extrapyramidal side effects at higher doses. Abbott India manufactures under WHO-GMP standards.
- Severe Nausea: Intense nausea from various causes responding to D2 receptor antagonism at CTZ;
- Severe Vomiting: Refractory vomiting requiring prescription antiemetic therapy;
- Chemotherapy Induced Nausea: Cancer chemotherapy nausea as adjunct or second-line therapy;
- Chemotherapy Vomiting: Cancer treatment vomiting responding to phenothiazine antiemetic;
- Post Surgical Nausea and Vomiting: Postoperative emesis prevention and treatment;
- Radiation Induced Nausea: Radiotherapy nausea and vomiting responding to D2 antagonism;
- Migraine Associated Nausea: Severe migraine-related nausea as adjunctive therapy;
- Vertigo: Vestibular disorders with vertigo including Meniere disease;
- Vestibular Disorders: Inner ear balance disorders with associated nausea;
- Gastroenteritis Vomiting: Severe infectious gastroenteritis nausea and vomiting;
- Schizophrenia: Psychotic disorder responding to first-generation antipsychotic therapy;
- Acute Psychotic Episodes: Acute psychosis requiring rapid dopamine D2 antagonism;
- Non Psychotic Anxiety: Short-term severe anxiety responding to sedating phenothiazine;
- Agitation: Acute agitation from various causes responding to calming effect;
- Cancer Treatment Support: Helping patients tolerate chemotherapy and radiation therapy;
- Refractory Nausea: Nausea unresponsive to first-line 5-HT3 antagonists;
- Dopamine D2 Antagonist Therapy: Drug class targeting D2 receptors for antiemetic action;
- Phenothiazine Antiemetic Class: First-generation phenothiazine with proven antiemetic efficacy;
- Dual Mechanism Antiemetic: Multi-receptor blockade for severe refractory nausea cases;
- Generic Compazine Therapy: Bioequivalent generic alternative to brand-name Compazine at lower cost.
- Fast Nausea Relief: Nausea suppression begins within 30-60 minutes of dosing;
- Less Vomiting Episodes: Vomiting frequency decreases substantially with D2 antagonism at CTZ;
- Better Chemotherapy Tolerance: Helps patients tolerate cancer treatments through nausea control;
- Better Cancer Treatment Adherence: Effective antiemetic prevents chemotherapy dose delays or discontinuation;
- Better Post Surgical Recovery: PONV prevention improves surgical recovery and hospital discharge;
- Better Migraine Nausea Control: Severe migraine-related nausea resolves alongside primary migraine therapy;
- Better Vertigo Symptom Relief: Vestibular disorder symptoms improve through combined D2 and H1 blockade;
- Less Acute Anxiety: Severe short-term anxiety decreases with calming phenothiazine action;
- Better Psychiatric Symptom Control: Schizophrenia symptoms improve with D2 antagonism;
- Better Acute Psychotic Episode Management: Acute psychosis responds to rapid D2 antagonism;
- Less Agitation: Acute agitation decreases with calming phenothiazine effect;
- Better Vestibular Function Support: Meniere disease and other vestibular disorders improve;
- Better Gastroenteritis Recovery: Severe infectious gastroenteritis vomiting controlled;
- Better Refractory Nausea Options: Provides alternative when 5-HT3 antagonists ineffective;
- Better Rehydration Support: Nausea control enables oral fluid intake preventing dehydration;
- Better Nutritional Intake: Reduced vomiting allows proper nutrition during illness recovery;
- Better Consistent 3-4 Hour Control: Sustained antiemetic effect between doses supporting stable function;
- Better Multi Mechanism Coverage: D2, H1, muscarinic, alpha-1 blockade for broad symptom relief;
- Better Generic Cost: 85-95% lower cost than brand Compazine makes proven antiemetic accessible;
- Better Quality of Life: Daily wellbeing improves dramatically as severe nausea and vomiting resolve.
Analogs:
Buccastem, Stemetil, Vertigon.

Generic Compazine (Prochlorperazine 5 mg) Medication guide:

💊 Compazine overview — phenothiazine antiemetic

Compazine (prochlorperazine) is a phenothiazine antiemetic used primarily for the control of severe nausea and vomiting. The drug was introduced in the 1950s originally for psychiatric use and quickly found its most durable role as one of the most reliable antiemetic medications available. It remains widely used today for chemotherapy-induced nausea, severe gastroenteritis vomiting, postoperative nausea, migraine-associated nausea, and vestibular vertigo.

💊 At a glance — what Compazine is

  • Class: Phenothiazine antiemetic (dopamine D2 antagonist)
  • Primary use: Severe nausea and vomiting; vertigo; migraine nausea
  • Available forms: 5 mg and 10 mg tablets; 25 mg suppositories; IM injection; oral syrup
  • Typical adult dose: 5-10 mg orally 3-4 times daily for nausea
  • Onset: 30-40 minutes orally; faster with IM or suppository
  • Duration: 3-4 hours; longer in older patients
  • Prescription: Required worldwide
  • Generic availability: Yes — widely available

👩‍⚕️ Doctor pearl — Dr. Hiroshi Tanaka

"Compazine has survived more than 70 years in clinical use because it works where many newer antiemetics do not reach. For patients with severe nausea that is not purely chemotherapy-related — viral gastroenteritis, migraines, vertigo spells, postoperative recovery — it remains one of the most reliable tools in the antiemetic toolkit. The key to using it well is dose-adjusting for the specific situation and watching for the characteristic phenothiazine side effects."

Compazine works through dopamine D2 receptor antagonism in the chemoreceptor trigger zone (CTZ) of the brainstem, the area that senses blood-borne emetic signals. This mechanism makes Compazine particularly effective for nausea driven by metabolic triggers, toxins, drug effects, and gastroparesis rather than motion sickness or purely vestibular causes. It also has useful anti-vertigo properties and some sedating effects that can help with the distress of severe vomiting episodes.

Patients often come to Compazine after trying ondansetron (Zofran) or other first-line antiemetics without full response. The combination of a 5HT3 antagonist like ondansetron plus a dopamine antagonist like Compazine is a classic multimodal approach for difficult nausea cases, with each drug targeting different receptor systems involved in the vomiting pathway.

🧬 How Compazine works — dopamine blockade mechanism

Compazine (prochlorperazine) is a typical phenothiazine with a piperazine side chain that gives it strong antiemetic activity with less sedation than aliphatic phenothiazines like chlorpromazine. Its primary mechanism for nausea control is blockade of dopamine D2 receptors in the chemoreceptor trigger zone (CTZ), located in the area postrema of the medulla. The CTZ lies outside the blood-brain barrier, which lets it detect blood-borne emetic signals from chemotherapy drugs, toxins, metabolic disturbances, and hormones.

🧬 Receptor profile

  • Dopamine D2 blockade — primary antiemetic mechanism (CTZ)
  • Histamine H1 blockade — sedation, anti-vertigo effect
  • Muscarinic blockade — dry mouth, blurred vision, constipation
  • Alpha-1 adrenergic blockade — orthostatic hypotension
  • Weak serotonin 5HT2 blockade — contributes to overall effect

🌊 The vomiting pathway and where Compazine works

🧫
Trigger
Chemo, toxins, gastroparesis, metabolic
📡
CTZ
Dopamine D2 signals
🚫
Compazine
Blocks D2 receptors
🧠
Vomiting center
No signal propagates
✅
Nausea stops
Patient feels relief

Because Compazine blocks dopamine receptors throughout the brain — not only in the CTZ — it can produce characteristic phenothiazine side effects including extrapyramidal symptoms (acute dystonia, akathisia, parkinsonism), sedation, orthostatic hypotension, and anticholinergic effects. These are generally manageable at antiemetic doses but become more problematic at higher doses or with chronic use.

⚠️ Why Compazine differs from ondansetron

Both drugs stop nausea but through different receptors. Ondansetron blocks serotonin 5HT3 receptors and works best for chemotherapy and postoperative nausea. Compazine blocks dopamine D2 and works more broadly across causes. For patients with chemo-related nausea, ondansetron is usually first choice; Compazine often adds benefit when ondansetron is inadequate. For vertigo-related nausea, Compazine often works better than ondansetron. For migraine nausea, Compazine is often preferred.

🎯 Indications — where Compazine works

Compazine has multiple approved and well-established off-label indications centered on nausea, vomiting, and vertigo control. Each has typical dosing patterns and preferred routes. The common thread is that Compazine works best for nausea driven by central mechanisms rather than motion sickness.

🎯 Indication Typical use Preferred route
Severe gastroenteritis vomiting5-10 mg every 6-8 hours as neededSuppository (if vomiting) or IM
Chemotherapy-induced nauseaAdded to ondansetron for refractory casesOral or IM
Postoperative nauseaRescue antiemetic in PACUIM or IV
Migraine with vomitingOften combined with triptan or NSAIDSuppository or IM
Vestibular vertigo (Meniere, labyrinthitis)5-10 mg orally during acute spellsOral
Gastroparesis flaresSecond-line after metoclopramideOral or suppository
Hyperemesis gravidarum (second trimester+)After doxylamine-pyridoxine; specialist decisionOral or suppository
Severe anxiety (historical use)Rarely used now; benzodiazepines preferredOral
Schizophrenia (historical use)Rarely used now; atypical antipsychotics preferredOral

✅ Where Compazine really shines

The sweet spot for Compazine is severe nausea with active vomiting — the suppository form lets patients get drug on board when oral medications would come right back up. For emergency department patients with gastroenteritis vomiting, migraines with intractable nausea, or chemotherapy breakthrough nausea, Compazine often works when nothing else has. The suppository route is particularly undervalued; patients are often reluctant but it works where oral is impossible.

🚨 What Compazine does NOT help

  • Pure motion sickness — use meclizine or scopolamine instead
  • Pregnancy-related morning sickness first trimester — use doxylamine-pyridoxine first
  • Alcoholic hangover — mostly supportive care
  • GERD-related nausea — treat underlying reflux
  • Psychogenic nausea — psychiatric evaluation first

📏 Dosing by route and age

Compazine dosing varies significantly by indication, patient age, severity, and route. The oral and suppository forms are most common for outpatient use; IM and IV routes are reserved for hospital or emergency department settings. Dosing follows the general principle of starting low, giving time to work, and escalating or repeating if needed rather than hitting with a large single dose.

📏 Form Adult dose Max daily
Oral tablet 5 mg5-10 mg every 6-8 hours40 mg antiemetic use
Oral tablet 10 mg10 mg every 6-8 hours40 mg antiemetic use
Suppository 25 mg25 mg twice daily50 mg
IM injection5-10 mg every 3-4 hours40 mg
IV (slow)2.5-10 mg; max 5 mg/min40 mg
Oral syrup 5 mg/5 mL1-2 teaspoons every 6-8 hours8 teaspoons

⚠️ Dosing in older adults

Patients over 65 should typically start at half the usual adult dose (2.5 mg oral or lower). Older patients are much more sensitive to the sedation, orthostatic hypotension, and extrapyramidal side effects of Compazine. Falls risk is a serious concern. For many older patients, ondansetron is preferred as first-line and Compazine is reserved for failures.

👶 Pediatric by weight Dose range
Under 9 kg or under 2 yearsCONTRAINDICATED
9-13 kg2.5 mg orally 1-2 times daily; max 7.5 mg/day
14-17 kg2.5 mg orally 2-3 times daily; max 10 mg/day
18-39 kg2.5 mg orally 3 times daily OR 5 mg twice daily; max 15 mg/day
Over 39 kgAdult dosing

💡 Practical dosing tips

  • Give oral dose with food if tolerated to reduce GI irritation
  • Suppositories work when oral cannot stay down — underutilized tool
  • Wait 30-45 minutes before adding more or switching routes
  • Scheduled dosing often works better than PRN for severe episodes
  • Taper after 3-5 days if used for a prolonged flare
  • IM injection stings — use Z-track technique and large muscle
  • IV must be slow — hypotension risk with rapid administration

🕐 Administration, timing, and route selection

How and when Compazine is given significantly affects both effectiveness and side effects. Timing matters for anticipating nausea triggers, dose spacing matters for avoiding peaks that cause side effects, and route selection matters for ensuring the drug actually gets absorbed.

🕐 When to take Compazine
  • At first sign of nausea — before escalation
  • 30-60 minutes before known triggers (chemo, meals for gastroparesis)
  • With meals if used chronically to reduce GI effects
  • Not at bedtime alone — falls risk from orthostasis
  • Scheduled during active flares rather than only PRN
  • Spaced 6-8 hours apart to avoid accumulation
🚫 When NOT to take
  • Just before driving unless well-tolerated
  • With other heavily sedating drugs same time
  • With alcohol
  • In large doses initially
  • Combined with other dopamine blockers
  • During Parkinson disease flares
  • Without water (oral)
🛣️ Route Onset Best use
Oral tablet30-40 minOutpatient, no active vomiting
Oral syrup20-30 minChildren, swallowing difficulty
Suppository30-60 minActive vomiting, outpatient setting
IM injection10-20 minEmergency department, severe nausea
IV slow5-15 minHospital setting; hypotension monitoring required

✅ Suppository technique

  • Unwrap carefully — keep refrigerated if available
  • Lubricate with water-based lubricant or warm it briefly in hand
  • Lie on side with lower leg straight and upper leg bent
  • Insert pointed end first, past the internal sphincter (about 1 inch adults)
  • Stay lying down for at least 15-20 minutes to prevent expulsion
  • Expect some discomfort initially; this fades
  • Effective even during vomiting because absorption bypasses the stomach

👥 Who should and should not use Compazine

Compazine is a versatile antiemetic, but it is not appropriate for everyone. Certain patient groups benefit particularly from it, while others face serious risks that make alternatives preferable. The decision usually weighs nausea severity, available alternatives, side effect risks, and patient age or comorbidities.

✅ Good candidates
  • Severe nausea unresponsive to ondansetron
  • Chemotherapy breakthrough nausea
  • Severe gastroenteritis with vomiting
  • Migraine with intractable nausea
  • Vestibular vertigo spells
  • Gastroparesis flares
  • Postoperative nausea rescue
  • Patients who need suppository option
🚫 Avoid or use with great caution
  • Parkinson disease or Lewy body dementia
  • Children under 2 or under 9 kg
  • Comatose or severely CNS-depressed patients
  • Severe bone marrow suppression
  • Reye syndrome risk (pediatric viral illnesses)
  • Known phenothiazine hypersensitivity
  • Pregnancy first trimester (relative)
  • Prior NMS or severe EPS
  • Significant QT prolongation
🤔 Patient profile Approach
Young adult, severe gastroSuppository 25 mg; good candidate
Pregnant woman, hyperemesisAfter doxylamine-pyridoxine and ondansetron; specialist decision
Older adult with migraineLow dose (2.5-5 mg); monitor BP; falls precautions
Chemotherapy patientAdjunct to ondansetron for breakthrough; schedule-based
Parkinson disease patientAVOID; worsens motor symptoms; use ondansetron
Child under 2CONTRAINDICATED; ondansetron is pediatric-safe alternative
Patient on multiple sedativesCaution; dose reduction; falls precautions

⚠️ The Parkinson rule

Compazine blocks dopamine receptors. Patients with Parkinson disease or related parkinsonian disorders depend on dopamine signaling for motor function. Giving Compazine to a Parkinson patient can cause severe worsening of rigidity, tremor, and bradykinesia that lasts days to weeks after the drug is stopped. For nausea in Parkinson patients, use ondansetron as first choice; it does not interfere with dopamine signaling.

🚀 Starting Compazine — first-dose approach

Starting Compazine well sets up the patient for success and limits side-effect surprises. The approach differs for acute single-event use (migraine, acute gastro) versus planned prophylactic use (chemotherapy, scheduled surgery) versus chronic use (gastroparesis flares, chronic vestibular disease). Each has its own starting pattern.

🏁 Before the first dose

  • Baseline BP including orthostatic readings
  • Medication list reviewed for interactions
  • Falls risk assessed (older adults, home environment)
  • Allergy history — prior phenothiazine reactions
  • Parkinson disease ruled out
  • Pregnancy status confirmed if applicable
  • EPS awareness — patient and family know what to watch for
  • Alcohol avoidance plan established

👩‍⚕️ Doctor pearl — Dr. Camila Rodrigues

"The most common mistake with Compazine is starting too high or giving too fast. For a patient with severe nausea, 5 mg orally with a small amount of water, waiting 30-40 minutes, is often enough. The urge to give 10 mg plus a suppository right away leads to orthostatic drops and sedation that discourage future use. Patient confidence in Compazine comes from a comfortable first experience; a bad first dose means they refuse it next time."

🚀 Scenario Starting approach
Acute viral gastroenteritis5-10 mg oral or 25 mg suppository; repeat in 6-8 hours as needed
Migraine with nausea10 mg oral or 25 mg suppository at onset; combined with triptan or NSAID
Chemotherapy adjunct5-10 mg oral every 6 hours scheduled for breakthrough
Vestibular vertigo5 mg oral at onset; repeat in 6 hours if needed
Older adult, any indicationStart at 2.5 mg; falls precautions in place
Chronic gastroparesis5 mg three times daily before meals; adjust based on response

⚠️ First 24 hours checklist

  • Patient aware of common sedation effect
  • No driving until response pattern known
  • BP checked after first dose if available
  • Patient knows signs of acute dystonic reaction
  • Family or caregiver aware of EPS symptoms
  • Water intake maintained
  • Fall prevention measures in place
  • Written instructions for repeat dosing
  • Alcohol avoidance confirmed
  • Follow-up contact information clear

📅 Daily routine with Compazine

For patients using Compazine for brief acute episodes, daily routine barely changes. For patients using it for chronic conditions like gastroparesis or recurring migraines, Compazine becomes part of the daily rhythm — timed with meals, scheduled around activities, and balanced against side effects that influence everything from driving to afternoon work.

📅 Example daily schedule — chronic gastroparesis patient on scheduled Compazine

7:00 AM
Wake slowly; sit at bedside 30 seconds; BP check if indicated
7:30 AM
Compazine 5 mg with small amount of water; 30-45 min before breakfast
8:00 AM
Small breakfast; sips of water throughout
10:00 AM
Light activity; avoid driving if sedation still present
12:30 PM
Compazine 5 mg before lunch
1:00 PM
Small lunch; chew well; small portions
3:00 PM
Rest period; avoid heavy work during peak sedation window
6:30 PM
Compazine 5 mg before dinner
7:00 PM
Small dinner; adequate chewing and spacing
9:00 PM
Avoid alcohol; relaxing activities only
10:30 PM
Bedtime; night light; bedside water
🏃 Activity Compazine consideration
DrivingAvoid during peak sedation window; most patients drive between doses once adjusted
ExerciseTimed between doses when alertness returns; hydrate; avoid hot environments
Work activitiesSchedule demanding work for pre-dose windows; let employer know if needed
Social eventsZero alcohol; drive escort; schedule dose timing around meal
TravelKeep supply in original container; adjust timing for time zone shifts gradually
Mornings with early appointmentsShift morning dose earlier; allow 60-90 min before leaving house

👩‍⚕️ Doctor pearl — Dr. Yusuf Al-Mansour

"The daily rhythm matters most for patients on scheduled Compazine. The afternoon dose is where many patients hit their drowsiness wall. For patients who work office jobs, I often shift the midday dose slightly earlier (12:00 noon instead of 1:00 PM) so the peak sedation window passes before mid-afternoon productivity hours. Small timing adjustments like this — based on the patient's actual schedule — keep people functional on Compazine for the long haul."

💧 Hydration and feeding alongside Compazine

Nausea and vomiting rapidly produce dehydration and electrolyte disturbance. Compazine controls the symptoms, but the underlying fluid losses still need active replacement. The approach combines frequent small sips rather than large volumes, electrolyte-containing fluids rather than plain water alone, and gradual return to solid food once vomiting is controlled.

💧
Small sips

15-30 mL every 10-15 min initially; larger as tolerated

🧂
Oral rehydration

Pedialyte, oral rehydration salts, or diluted sports drink

🍚
BRAT progression

Bananas, rice, applesauce, toast when nausea controlled

🕔 Timeline Fluid strategy Food strategy
First hour after CompazineNothing; let drug workNothing
Hours 1-2Ice chips if tolerated; tiny sipsNothing
Hours 2-4Oral rehydration solution 30 mL every 15 minDry crackers if tolerated
Hours 4-8Larger sips; broth; diluted juiceBRAT foods; small portions
Day 2+Normal fluid intake; monitor urine colorExpand diet gradually; avoid fatty or spicy foods

🚨 Signs of dangerous dehydration

  • Minimal urine for 8+ hours
  • Dark concentrated urine
  • Dizziness or near-fainting when standing
  • Rapid heart rate at rest
  • Sunken eyes or dry mucous membranes
  • Confusion or lethargy
  • Children: no tears when crying; dry diapers
  • → Emergency department for IV fluids

💉 Compazine for chemotherapy nausea

Chemotherapy-induced nausea and vomiting (CINV) is one of the most feared side effects of cancer treatment. Modern multidrug antiemetic regimens have made it much more controllable than it was 30 years ago, but breakthrough nausea still occurs in a meaningful fraction of patients. Compazine fills important niches in CINV management, particularly as a reliable breakthrough rescue agent.

💉 CINV phase Timing Compazine role
AnticipatoryBefore chemo (conditioned)Benzodiazepines preferred; Compazine not first choice
AcuteWithin 24 hours of chemoBackup to ondansetron + dexamethasone
DelayedDays 2-5 after chemoCommon use; scheduled Compazine 5-10 mg every 6-8 hours
BreakthroughAny time despite prophylaxisWorkhorse rescue; suppository 25 mg if vomiting
RefractoryNot responding to standard approachScheduled Compazine + other adjuncts; oncology input

✅ Multimodal CINV antiemetic combinations

  • Highly emetogenic chemo: NK1 antagonist (aprepitant) + 5HT3 (ondansetron) + dexamethasone; Compazine as breakthrough
  • Moderately emetogenic chemo: 5HT3 + dexamethasone; Compazine as breakthrough
  • Delayed nausea (days 2-5): dexamethasone + metoclopramide or Compazine scheduled
  • Breakthrough: add Compazine suppository or oral; consider adding another receptor class
  • Refractory cases: olanzapine at 2.5-5 mg daily plus standing Compazine

👩‍⚕️ Doctor pearl — Dr. Hiroshi Tanaka

"For delayed nausea days 2-5 after chemotherapy, scheduled Compazine 5-10 mg every 6-8 hours often outperforms ondansetron, which loses efficacy in the delayed phase. Patients receiving moderately emetogenic chemo who go home with scheduled Compazine for 72 hours report significantly better quality of life than those given only PRN rescue. The key is scheduled dosing — not waiting for nausea to arrive."

⚠️ Cancer patient considerations

  • Monitor for akathisia — often misread as cancer anxiety
  • Falls precautions — cancer patients often weakened; orthostasis adds risk
  • Bone marrow effects rare at antiemetic doses; monitor CBC if used chronically
  • Interactions with other QT-prolonging cancer drugs (methadone, haloperidol)
  • Suppository option valuable when oral is impossible
  • Communicate with oncology about dosing schedule

🤕 Compazine for migraine with nausea

Migraine attacks commonly include severe nausea and vomiting that both worsen patient distress and interfere with oral absorption of migraine abortive medications. Compazine has two useful effects for migraine: it stops the nausea directly, and it has some independent anti-migraine activity through dopamine antagonism in migraine pathways. Many emergency departments use Compazine as part of standard migraine cocktails.

🏥 Emergency department migraine cocktail
  • IV fluids: normal saline 500-1000 mL
  • Compazine 10 mg IV slow push over 2-5 min
  • Diphenhydramine 25-50 mg IV to prevent akathisia
  • Ketorolac 15-30 mg IV or IM
  • Sumatriptan 6 mg SC if no triptan same day
  • Magnesium 1-2 g IV for aura migraines
  • Dexamethasone 4-10 mg IV to prevent recurrence
🏠 Home migraine protocol
  • Compazine 25 mg suppository or 10 mg oral at onset
  • Triptan if usual migraine abortive
  • NSAID if tolerated
  • Hydration as tolerated
  • Dark quiet room
  • Lie down 30-60 min after Compazine
  • Repeat Compazine in 6 hours if needed
🤔 Scenario Compazine approach
Mild migraine, nausea main complaintOral Compazine 10 mg; may suffice alone
Moderate migraine with nauseaCompazine + triptan at onset
Severe migraine with vomitingCompazine suppository first; triptan after absorbed
Chronic migraine, frequent attacksCompazine for breakthrough; preventive strategy from headache specialist
Status migrainosusEmergency department; IV cocktail including Compazine
Pregnancy with migraineSpecialist decision; metoclopramide often preferred; Compazine after first trimester

⚠️ Akathisia prevention with migraine use

Patients receiving IV Compazine for migraine have a meaningful risk of akathisia (restless agitation that feels terrible). Routinely giving diphenhydramine 25 mg alongside Compazine prevents or minimizes this uncomfortable reaction. For home oral use, akathisia is less common but can still occur; patients should know what it feels like so they can report it rather than suffer silently.

🌊 Compazine for vertigo and vestibular disorders

Vertigo-related nausea is one of the most distressing combinations in medicine. Patients cannot tell which way is up, feel violently nauseated, and often vomit uncontrollably. Compazine addresses this through both anti-vertigo and antiemetic effects, making it particularly useful for acute vestibular episodes from Meniere disease, labyrinthitis, vestibular neuritis, and benign paroxysmal positional vertigo (BPPV) with severe nausea.

🌊 Vestibular condition Compazine role
Meniere disease acute attack5-10 mg oral or 25 mg suppository; attacks typically 20 min to several hours
Vestibular neuritis5-10 mg every 6-8 hours first 48 hours; taper as acute phase resolves
LabyrinthitisSimilar to neuritis; often with hearing changes
BPPV with severe nauseaShort course during acute distress; Epley maneuver treats underlying problem
Vestibular migraineCompazine useful for both components; migraine prevention long-term
Chronic vertigoPRN for severe spells; vestibular rehab is primary treatment

⚠️ Why not use Compazine chronically for vertigo

Vestibular suppressants like Compazine, meclizine, and benzodiazepines interfere with central compensation, the brain's natural process of adapting to vestibular injury. Short courses during acute severe episodes are helpful; longer-term suppression delays recovery and perpetuates symptoms. For most vestibular conditions, Compazine use should be limited to 3-5 days during acute distress, then vestibular rehabilitation takes over.

📌 Vestibular rehabilitation role

  • Vestibular PT is cornerstone of recovery
  • Habituation exercises help brain adapt to altered input
  • Compazine should be stopped during vestibular rehab sessions
  • Progress is faster when suppressants are minimized
  • Short-term rescue for severe breakthrough spells is OK
  • Communication with the vestibular therapist about medication use

👩‍⚕️ Doctor pearl — Dr. Fiona McKenzie

"For emergency department vestibular presentations, I use Compazine 10 mg IV along with IV fluids. The patient often comes in miserable, unable to tolerate any oral medication, and feeling like the room is spinning violently. Within 30-45 minutes they are usually comfortable enough to open their eyes, drink some water, and have a focused neurologic exam. The combination of Compazine and fluid resuscitation is a reliable workhorse for acute vestibular distress — just make sure to also rule out stroke in anyone with concerning features."

🩺 Compazine for postoperative nausea

Postoperative nausea and vomiting (PONV) is one of the most common and distressing complications of surgery with general anesthesia. Modern perioperative antiemetic protocols have reduced PONV significantly, but breakthrough nausea still occurs. Compazine serves as a reliable second-line or rescue agent when first-line antiemetics (ondansetron, dexamethasone) are inadequate.

🩺 Perioperative phase Compazine role
Preoperative prophylaxisRarely used; ondansetron + dexamethasone preferred
IntraoperativeCan be given as third-agent prophylaxis in high-risk patients
PACU breakthroughCommon use; 2.5-10 mg IM or slow IV
Ward-level nauseaOral 10 mg or suppository 25 mg every 6-8 hours as needed
Discharge homeOral or suppository prescription for home use

📊 High-risk PONV patients

  • Female sex
  • Non-smoker
  • History of PONV or motion sickness
  • Postoperative opioid use
  • Gynecologic, abdominal, or ENT surgery
  • Volatile anesthetic exposure
  • Longer duration of surgery
  • Children over age 3 (adult risk pattern)
  • → Multi-agent prophylaxis including Compazine in refractory cases

✅ Postop recovery tips

  • Report nausea early — easier to treat before vomiting starts
  • Position matters — sitting up often helps
  • Slow fluid progression — ice chips first, then clear liquids
  • Avoid strong smells — perfumes, food odors can trigger
  • Ginger may help as adjunct
  • Acupressure wristbands have modest evidence
  • Walking as soon as safe helps return of bowel function
  • Minimize opioids if nausea is a major issue

⚠️ Perioperative drug interactions

Compazine during the perioperative period interacts with anesthetic agents, opioids, and other CNS depressants. The combined sedation can slow emergence from anesthesia and prolong PACU stay. Anesthesia teams balance antiemetic benefit against sedation risk; younger healthier patients tolerate the combination well, older or frail patients need more caution. Communication with the anesthesia team about recent Compazine use is essential if additional sedatives are planned.

👩‍👩‍👧 Family communication and caregiver guidance

Family members often help manage patients using Compazine, particularly for severe acute illness, chemotherapy recovery, migraine attacks, and older adult care. The caregiver's awareness of what Compazine does, what side effects to watch for, and when to seek more help directly affects outcomes. A well-informed family can prevent many of the complications associated with phenothiazine antiemetics.

👩‍👩‍👧 Family briefing — what to tell loved ones

  • What it is: Antiemetic to stop severe nausea and vomiting
  • How it works: Blocks dopamine signals that trigger vomiting
  • Takes 30-45 minutes to start working
  • Expected effects: Sleepy, maybe dizzy when standing; nausea stops
  • Watch for: Muscle spasms (face, neck, back), restlessness, severe stiffness
  • Help with: Standing slowly, water sips, light food when ready
  • Avoid: Alcohol, driving, operating equipment
  • Call doctor: If spasms occur, no improvement in 2 hours, or getting worse
  • Call 911: High fever + rigidity + confusion; severe allergic reaction
📞 Situation Family action
First dose at homeStay with patient 60-90 min; help with sips of water; falls precautions
Standing from bedHelp patient sit at bedside 30 sec first; walk with them initially
Nausea not better in 2 hoursCall prescriber; may need second dose or different route
Patient looks very sleepyExpected; let them rest; monitor breathing; wake for next dose
Jerky movements, neck twistingEmergency — acute dystonic reaction; ED needed
Patient agitated, pacingAkathisia — call prescriber; needs treatment
High fever and rigid musclesCall 911 — possible NMS

👩‍⚕️ Doctor pearl — Dr. Yusuf Al-Mansour

"Family members are often the first to notice acute dystonic reactions and akathisia because the patient themselves is distracted by nausea and sedation. Teaching family what these look like — the involuntary neck twisting of a dystonic reaction, the uncontrollable urge to move that defines akathisia — makes them a crucial safety layer. I always spend five minutes briefing family before sending a patient home with Compazine. The time pays off repeatedly."

🧠 Mental health effects and akathisia awareness

Compazine is a dopamine antagonist, which places it in the same chemical family as antipsychotic medications. For most patients using it for nausea at antiemetic doses, mental health effects are modest — mild sedation, occasional dysphoria. For some patients, however, Compazine can produce significant psychological effects including depression, apathy, akathisia (which can feel like severe anxiety), and rare psychotic symptoms. Awareness of these effects helps patients and clinicians distinguish drug reactions from unrelated psychiatric symptoms.

🚨 Compazine-related mental health concerns

  • Akathisia — distressing inner restlessness; often mistaken for anxiety
  • Dysphoria — "feeling flat" or down after doses
  • Depression with chronic use
  • Apathy or emotional blunting
  • Confusion particularly in older adults
  • Hallucinations rare but possible
  • Worsening of underlying depression
  • Anxiety symptoms that can mimic the akathisia
🤔 Symptom What it might mean
Pacing, cannot sit stillAkathisia — drug-induced; stop or reduce; treat with lorazepam or propranolol
Feeling flat, disconnectedPossible drug effect; usually improves after stopping
New depressed mood on long courseConsider drug contribution; reassess need; alternative antiemetics
Confusion, memory issuesCommon in older adults; reduce dose; consider ondansetron
Vivid dreams or nightmaresNot uncommon; shift evening dose earlier
Anxiety that feels physicalVery likely akathisia — treat as drug reaction

⚠️ The akathisia misdiagnosis trap

Akathisia is a drug-induced inner restlessness that patients often describe as "I feel like I need to crawl out of my skin." It is frequently misdiagnosed as anxiety, agitation from illness, or psychiatric decompensation. The treatment is to stop or reduce the Compazine, not to add more sedatives or psychiatric medications. Benzodiazepines (lorazepam) or beta-blockers (propranolol) can be used short-term while the Compazine clears. Recognition is the whole battle — once identified, akathisia is very treatable.

💡 Pre-existing mental health considerations

  • Depression history — monitor for worsening with chronic use
  • Anxiety disorders — be particularly alert for akathisia misdiagnosis
  • Schizophrenia on other antipsychotics — coordinate with psychiatry
  • Bipolar disorder — usually manageable with monitoring
  • Alcohol use disorder — interaction concerns; limited supply
  • Older adults with dementia — prefer ondansetron; delirium risk
  • Patient history of EPS or NMS — avoid Compazine entirely

🚶 Physical activity on Compazine

Physical activity while using Compazine requires some adjustments. The sedation and orthostatic hypotension effects make certain activities less safe during peak drug periods, while maintaining physical activity during recovery from the underlying illness is important. The approach combines timing activities between doses, modifying intensity, and specific precautions for falls-prone situations.

🚶
Generally safe

Light walking, gentle stretching, slow range of motion

⚠️
Caution during peak

Running, cycling, moderate strength training

🚫
Avoid during peak

Driving, swimming, heights, machinery, contact sports

🏃 Activity Compazine consideration
Walking around homeKeep active during recovery; use handrails on stairs; hold furniture when standing
Light outdoor walkingOK between dose peaks; carry phone; have escort if BP unstable
Household choresAvoid heavy lifting during peak sedation; break into shorter sessions
Regular exercise routineShift to pre-dose windows; reduce intensity; hydrate aggressively
Yoga or PilatesAvoid rapid position changes; floor work OK; standing poses carefully
SwimmingAvoid during peak; drowning risk from sedation; always with companion
HikingCaution on uneven terrain; hiking poles; well-marked trails; cell signal
Gym machinesTreadmill at lower speeds; stability of weight machines preferred over free weights
Group fitness classesModify intensity; drink water liberally; sit if dizzy

💡 Movement principles on Compazine

  • Hydrate before, during, after — dehydration worsens hypotension
  • Avoid hot environments during peak dose window
  • Cool-down slowly after exercise
  • Monitor for dizziness and stop if present
  • Fuel adequately before exercise if nausea is controlled
  • Buddy system helpful during first week
  • Rest periods incorporated into routine
  • Floor-based activities often safer than standing

👩‍⚕️ Doctor pearl — Dr. Camila Rodrigues

"Patients recovering from severe nausea sometimes stay too sedentary once Compazine controls the vomiting. Light movement — even just walking to the kitchen and back — speeds recovery of bowel function, prevents deconditioning, and improves mood. The dose-recovery routine I recommend: dose with meal, rest 60-90 min, light movement for 10-20 min, repeat. Movement is medicine for the gut; sedation is not an excuse for immobility."

📓 Symptom and medication diary

For patients using Compazine for chronic or recurring nausea conditions (gastroparesis, chronic migraine, cyclical vomiting syndrome, chemo cycles), a symptom and medication diary helps patients and clinicians make better decisions. The diary tracks nausea severity, dose timing, response, side effects, and functional outcomes.

📓 Example diary template

Date: Oct 17
Nausea severity (0-10): 7 at 9 AM, 3 by noon
Vomiting episodes: 2 before Compazine; 0 after
Compazine dose/time: 10 mg oral at 9:15 AM
Time to relief: approx 40 min
Side effects: moderate drowsiness; mild dry mouth
Oral intake: tolerated 500 mL fluids by lunch
Food: dry toast at 1 PM
Functional note: back to work at 2 PM
Next dose planned: 4 PM if nausea returns
📊 What to track Why it matters
Nausea severity scaleTracks response objectively vs vague "better" or "worse"
Vomiting episodesClearest outcome measure for antiemetic effect
Dose timing and amountIdentifies optimal timing patterns
Time to reliefIf longer than 45-60 min, consider route change
Side effectsPatterns inform dose adjustment or alternative drug
Oral intakeHydration status; indicates functional recovery
Food toleranceGuides diet progression
Functional statusReturn to work, driving, exercise
Triggers identifiedPattern recognition over time

✅ Diary benefits over time

  • Identifies trigger patterns (foods, stress, menstrual cycles, weather)
  • Shows actual medication need vs assumed frequency
  • Documents functional outcome for insurance or disability
  • Supports dose adjustments based on data not guess
  • Catches tolerance development if effect wanes over time
  • Flags side effect patterns early
  • Supports communication with prescriber at visits
  • Helpful when switching providers for continuity

😴 Sleep management with Compazine

Sleep interacts with Compazine in several ways: nausea itself disrupts sleep, Compazine causes significant sedation, poor sleep worsens nausea thresholds the next day, and bedtime dosing can produce morning hangover. For patients using scheduled Compazine, strategic timing of the last dose matters significantly for both sleep quality and daytime function.

😴 Sleep principles on Compazine

  • Consistent bedtime within 30 min same time nightly
  • 7-9 hours total
  • Last Compazine dose 3-4 hours before bed if possible
  • Avoid bedtime-only Compazine — morning sedation worse
  • Cool dark bedroom
  • Pre-sleep hydration tapered to avoid nocturia with falls risk
  • Bedside water for dry mouth
  • Nighttime toileting plan — night light, bedside commode if needed
🌙 Sleep problem Compazine-specific approach
Nausea waking patient at nightSuppository available at bedside; consider scheduled evening dose
Morning hangover sedationShift last dose earlier; reduce bedtime dose; skip bedtime if evening dose adequate
Nightmares or vivid dreamsFairly common; shift evening dose earlier; usually improves after 1-2 weeks
Rising at night to urinateFalls risk high; night light; sit at bedside 30 sec; consider bedside commode
Insomnia despite CompazineSleep hygiene; CBT-I; usually not from Compazine effect itself
Dry mouth waking patientBedside water; humidifier; sugar-free lozenges
Restless legs or akathisia at nightCall prescriber — drug reaction; may need to stop Compazine

🚨 Nocturnal fall prevention on Compazine

Patients on Compazine rising at night to urinate have significant falls risk from the combined effects of sedation, orthostatic hypotension, and dim lighting. Prevention: sit at bedside for 30 seconds before standing; night light on bathroom path; grab bars near bed and in bathroom; bedside commode if transfers are difficult; limit evening fluid intake to reduce nocturia; keep phone within reach in case of fall.

⚠️ Side effects: sedation, EPS, hypotension, NMS

Compazine side effects fall into four main categories: sedation and anticholinergic effects (dry mouth, blurred vision, constipation), cardiovascular effects (orthostatic hypotension, QT prolongation), extrapyramidal symptoms (acute dystonia, akathisia, parkinsonism, rare tardive dyskinesia), and the serious but rare neuroleptic malignant syndrome (NMS). Most patients experience mild versions of the first category; the serious concerns are the EPS reactions, severe hypotension, and NMS.

📊 Side effect frequency on Compazine (approximate)

😴 Sedation / drowsiness
~40-60%
🤢 Dry mouth
~20-35%
🖤 Orthostatic hypotension
~10-20%
🚶 Akathisia
~5-15%
💫 Dizziness
~10-15%
🚽 Constipation
~5-10%
💥 Acute dystonia
~1-5%
🧊 Parkinsonism
~1-3%
☠️ NMS (rare)
<0.1%
🟡 Expected but manageable
  • Mild to moderate drowsiness
  • Dry mouth
  • Mild dizziness when standing
  • Blurred vision briefly
  • Mild constipation
  • Nasal congestion
🚨 Warning signs
  • Acute dystonic reaction (neck twisting, eye rolling, back arching)
  • Severe akathisia
  • Severe hypotension or syncope
  • High fever with rigidity (NMS)
  • Severe allergic reaction
  • Prolonged QT with syncope
  • Severe parkinsonism
  • Hallucinations or psychotic symptoms

🚨 Red flags — stop drug or seek emergency care

  • Acute dystonic reaction — emergency department; IV diphenhydramine or benztropine
  • Neuroleptic malignant syndrome signs (fever + rigidity + confusion + autonomic instability) — 911
  • Severe allergic reaction — 911
  • Syncope — emergency evaluation; discontinue
  • Severe tardive dyskinesia on chronic use — discontinue
  • Agranulocytosis signs (severe sore throat, fever, mouth ulcers) — emergency CBC
  • QT prolongation symptoms (palpitations, syncope) — cardiac evaluation

👩‍⚕️ Doctor pearl — Dr. Lena Fischer

"The pattern of Compazine side effects follows a predictable timeline. Sedation and dry mouth show up with the first dose. Orthostatic hypotension develops over the first few hours. Acute dystonic reactions appear within hours to days. Parkinsonism develops over weeks. Tardive dyskinesia emerges only after months of chronic use. Knowing this timeline helps distinguish Compazine effects from unrelated symptoms and informs how aggressively to monitor for each category."

🧊 Extrapyramidal symptoms — recognition and treatment

Extrapyramidal symptoms (EPS) are Compazine's most characteristic side effect class and the one patients fear most. The four EPS syndromes — acute dystonia, akathisia, drug-induced parkinsonism, and tardive dyskinesia — have different presentations, timelines, and treatments. Recognition is essential because these reactions are treatable and sometimes reversible when caught early.

💥 Acute dystonia
  • Timing: Hours to days after start
  • Features: Neck twisting, eye deviation, tongue protrusion, back arching, jaw spasm
  • Risk: Young males especially
  • Treatment: IV diphenhydramine 25-50 mg or benztropine 1-2 mg
  • Response: Within 15-30 minutes
  • Prevention: Prophylactic diphenhydramine with first dose
🚶 Akathisia
  • Timing: Hours to weeks
  • Features: Inner restlessness; cannot sit still; "crawling out of skin"
  • Risk: Any age; often misdiagnosed as anxiety
  • Treatment: Stop Compazine; propranolol 10-20 mg BID; lorazepam 0.5-1 mg
  • Response: Hours to days after stopping
  • Prevention: Lowest effective dose; patient education
🧊 Parkinsonism
  • Timing: Days to weeks
  • Features: Tremor, rigidity, bradykinesia, mask face, shuffling gait
  • Risk: Older patients; chronic use
  • Treatment: Stop or reduce Compazine; may add anticholinergic
  • Response: Weeks to months after stopping
  • Prevention: Avoid chronic use; alternatives in elderly
🐺 Tardive dyskinesia
  • Timing: Months to years of chronic use
  • Features: Involuntary movements (lip smacking, tongue, limbs); often permanent
  • Risk: Older patients; cumulative dose matters
  • Treatment: Stop Compazine; VMAT2 inhibitors (valbenazine, deutetrabenazine)
  • Response: May persist indefinitely
  • Prevention: Minimize chronic use; limit cumulative exposure

🚨 Acute dystonic reaction is a medical emergency

Acute dystonia from Compazine can involve the laryngeal muscles and cause airway compromise. Any patient with Compazine use plus neck twisting, severe jaw spasm, difficulty swallowing, or breathing difficulty needs immediate emergency care. Treatment with IV diphenhydramine typically produces rapid resolution. The reaction almost never recurs when the responsible drug is stopped.

⚠️ EPS risk reduction strategies

  • Lowest effective dose — especially important in elderly
  • Shortest reasonable duration — avoid chronic use when possible
  • Patient education on what to watch for
  • Prophylactic diphenhydramine for IV use in high-risk patients
  • Avoid in Parkinson disease
  • Caution in young males for first-time use (dystonia risk)
  • Consider ondansetron first when both would work
  • Document any EPS reaction clearly in medical record

🖤 Managing Compazine-related hypotension

Orthostatic hypotension on Compazine arises from alpha-1 adrenergic blockade, which prevents the normal vascular constriction that keeps BP stable with position changes. The drop is most pronounced within 1-2 hours of each dose and during titration. Management combines careful positioning habits, dose adjustments, and awareness of situations that worsen the effect.

🚨 Hypotension warning signs

  • Dizziness on standing (especially from lying or sitting)
  • Blurred vision briefly after standing
  • Lightheadedness
  • Near-syncope
  • Syncope
  • Falls
  • BP drop over 20 mm Hg systolic on standing
  • Compensatory tachycardia
🛡️ Protective habits
  • Stand up slowly from sitting or lying
  • Sit at bedside 30 seconds before standing
  • Hold onto furniture when standing
  • Pump calf muscles before standing
  • Rise in stages: lie to sit, pause, stand
  • Avoid prolonged standing still
  • Sit if feeling lightheaded
💚 Things that help BP
  • Adequate hydration
  • Normal salt intake
  • Compression stockings for severe cases
  • Smaller more frequent meals
  • Elevate head of bed slightly
  • Avoid hot showers right after dose
  • Dose timing adjustment
  • Dose reduction if persistent
🤔 Scenario Approach
Mild dizziness on standingContinue with careful standing habits; usually improves after 2-3 days
Significant orthostatic dropDose reduction; separate from antihypertensive dosing
Falls from standing upPrompt dose reduction; fall prevention; consider switch to ondansetron
SyncopeEmergency evaluation; discontinue; rule out other causes
Already on antihypertensivesReview BP regimen; may need adjustment during Compazine course
Dehydration from the illness itselfAggressive rehydration; may need IV fluids

⚠️ IV route hypotension risk

Rapid IV administration of Compazine can cause severe acute hypotension with syncope. The drug must be given slowly (over 2-5 minutes), the patient monitored during administration, and typically with IV fluid running. Hospital protocols often require continuous BP monitoring for 30 minutes after IV Compazine. Patients already orthostatic from the underlying illness (dehydration from vomiting) are at highest risk.

🚗 Driving and daily operation on Compazine

Driving on Compazine requires caution because sedation, dizziness, hypotension-related symptoms, and blurred vision are common. Most patients should avoid driving during the peak dose window (1-3 hours after dose) and may be able to drive safely between doses once their body has adjusted. Honest self-assessment is essential.

🚗 Driving guidance
  • First week: avoid driving until response pattern known
  • Peak dose window (1-3 h post-dose): no driving
  • Stable, no symptoms: usually OK between doses
  • After dose increase: reassess
  • Combined with other sedatives: no driving
  • Acute illness episode: no driving regardless
🚦 Risk factors for impaired driving
  • Recent dose increase
  • Alcohol same day
  • Other sedating medications
  • Older age
  • Early morning or late night driving
  • Monotonous highway driving
  • Blurred vision from drug
  • Underlying illness still active
🕐 Time pattern Driving appropriateness
Within 1-3 h of doseAvoid driving — peak sedation and hypotension window
3-6 h after doseShort local drives if alert and symptom-free
Pre-dose windowOften best driving window
Night drivingCaution; fatigue plus bedtime dose effect
Long highway drivesBreaks every 90 min; stop if drowsy
After alcoholZero drinks if driving same day on Compazine

⚠️ Short course vs chronic use driving

For short-course use (3-5 days during an acute illness), driving should typically be avoided throughout. For chronic use, patients eventually develop some tolerance to the sedation and can drive between doses, but the orthostatic hypotension and blurred vision risks continue. Commercial drivers (truck, bus, taxi, pilot) usually need to discuss Compazine use with occupational medicine; alternative antiemetics may be more appropriate for employment-critical driving.

👨‍🦳 Older adults — use with great caution

Older adults using Compazine require particular caution because of the combination of enhanced sedation sensitivity, higher falls risk from orthostatic hypotension, higher EPS risk (particularly parkinsonism and tardive dyskinesia), anticholinergic cognitive effects, and often multiple sedating medications. Many geriatric medicine guidelines include Compazine on potentially inappropriate medications lists for older adults.

🌡️ Compazine appropriateness by age
18-5455-6465-7475-8485+
🟢 Standard🟢 Standard🟡 Lower start🟡 Prefer alternatives🔴 Avoid if possible
👴 Age-related consideration Adjustment
Increased hypotension sensitivityLower starting dose; slower titration; falls precautions
Higher EPS riskMinimize chronic exposure; alternatives preferred
Anticholinergic cognitive effectsCan worsen cognition; especially problematic with dementia
Falls riskLower doses; environmental fall prevention; walker if needed
PolypharmacyReview for sedatives, anticholinergics, QT-prolonging drugs
DementiaAvoid — use ondansetron instead; delirium risk

⚠️ Beers Criteria consideration

The American Geriatrics Society Beers Criteria lists phenothiazines like Compazine as potentially inappropriate for older adults, particularly those with cognitive impairment or history of falls. This does not mean Compazine is forbidden in older adults, but that alternatives should be considered first and the risk-benefit calculation should be explicit. Ondansetron is often preferred as first-line antiemetic in older adults.

🚨 When to prefer ondansetron over Compazine in older adults

  • Dementia or significant cognitive impairment
  • Falls in the past year
  • Parkinson disease or atypical parkinsonism
  • Multiple sedating medications already
  • Significant baseline orthostatic hypotension
  • Prior EPS reaction to any dopamine antagonist
  • Living alone without caregiver support
  • Chronic use anticipated

📋 Older adult Compazine checklist

  • Baseline BP including orthostatic measurements
  • Cognitive baseline documented
  • Falls history and risk assessment
  • Medication reconciliation for sedatives, anticholinergics, QT drugs
  • Parkinson disease screening
  • Home safety evaluation
  • Caregiver aware of what to watch for
  • Starting dose 2.5-5 mg maximum
  • Shortest effective duration
  • Reassess need frequently

🤰 Pregnancy and breastfeeding with Compazine

Compazine use during pregnancy has decades of accumulated clinical experience but limited rigorous safety data. The drug is categorized as pregnancy category C under older FDA classification. Current practice avoids first-trimester use when possible, considers Compazine reasonable in second and third trimesters for severe nausea or hyperemesis gravidarum unresponsive to safer alternatives, and uses the lowest effective dose for the shortest necessary duration.

🤰 Pregnancy period Compazine approach
Pregnancy planningIf used chronically, discuss with specialist; often tapered before conception
First trimesterPrefer doxylamine-pyridoxine first; then ondansetron; Compazine third-line
Second trimesterReasonable for severe nausea; lowest effective dose
Third trimesterCan be used; close to delivery, neonatal effects considered
Near deliveryAvoid if possible — neonatal EPS and respiratory effects reported
Hyperemesis gravidarum severeReasonable option after other agents inadequate; MFM consultation
BreastfeedingSmall amounts transfer; brief use usually compatible; monitor infant for sedation

✅ Pregnancy antiemetic ladder

  • Step 1: Lifestyle (small meals, ginger, acupressure)
  • Step 2: Doxylamine-pyridoxine (Diclegis/Diclectin)
  • Step 3: Ondansetron (after first trimester; some data in first trimester)
  • Step 4: Metoclopramide or Compazine
  • Step 5: Combination therapy; corticosteroids for refractory cases
  • Severe hyperemesis: Hospitalization, IV fluids, parenteral antiemetics

⚠️ Neonatal considerations

Phenothiazines like Compazine given near delivery can produce neonatal effects including EPS symptoms, respiratory depression, feeding difficulties, and withdrawal symptoms. These typically resolve within days to weeks after birth but may require neonatal observation. For pregnant women needing Compazine near term, neonatology coordination is appropriate so the newborn is observed for these effects.

👶 Breastfeeding considerations

Compazine passes into breast milk in small amounts. For brief use during an acute illness, breastfeeding is generally compatible with monitoring the infant for sedation. For chronic use, alternatives are preferred. Timing the dose right after breastfeeding maximizes the interval before the next feeding and reduces infant exposure. Pumped milk from the first 2-4 hours after a dose can be discarded if the mother prefers; this is cautious but not strictly necessary for most patients.

👶 Pediatric considerations with Compazine

Compazine use in pediatric patients is restricted and specialist-managed. The drug is contraindicated in children under 2 years or weighing less than 9 kg. For older children, it can be used for severe nausea but requires weight-based dosing, careful observation for Reye syndrome risk during viral illnesses, and awareness that dystonic reactions are more common in children and young adults than in middle-aged patients.

🚨 Pediatric contraindications and cautions

  • Under 2 years or under 9 kg: CONTRAINDICATED
  • During viral illnesses in children: Reye syndrome risk (controversial, generally avoid in context of fever + viral symptoms)
  • Dehydration with electrolyte abnormality: Higher EPS risk
  • Prior dystonic reaction: Avoid
  • Prolonged vomiting with unknown cause: Rule out surgical abdomen first
  • Neurologic disease: Caution and specialist input
👶 Weight Dose Max daily
Under 9 kgCONTRAINDICATED—
9-13 kg2.5 mg oral 1-2x daily7.5 mg
14-17 kg2.5 mg oral 2-3x daily10 mg
18-39 kg2.5 mg 3x daily or 5 mg 2x daily15 mg
Over 39 kgAdult dosing40 mg

⚠️ Ondansetron is pediatric first-line

For most pediatric nausea situations, ondansetron is now preferred as first-line antiemetic because it works well in children, lacks the EPS risks of Compazine, and has established pediatric dosing. Compazine remains useful for refractory cases, children with chemotherapy-induced nausea unresponsive to ondansetron, and specific situations requiring Compazine's broader receptor profile. Pediatric prescribing should involve a pediatrician or pediatric specialist.

💊 Drug interactions

Compazine has several clinically important drug interactions, driven by its dopamine antagonism, anticholinergic properties, QT prolongation potential, and additive CNS depressant effects. A thorough medication review is essential before and during Compazine use.

💊 Medication class Interaction Significance
AlcoholAdditive sedation and hypotensionAvoid; falls, respiratory depression
OpioidsAdditive sedation; respiratory depressionCaution; dose coordination
BenzodiazepinesAdditive sedationCaution; falls risk
LevodopaCompazine antagonizes dopamineAvoid combination; worsens Parkinson disease
Other antipsychoticsAdditive EPS and NMS riskCaution; psychiatry coordination
QT-prolonging drugsAdditive QT prolongationReview; some combinations contraindicated
Anticholinergic drugsAdditive dry mouth, constipation, cognitive effectsReview; particularly in elderly
AntihypertensivesAdditive BP loweringDose coordination; home BP monitoring
TramadolSeizure threshold loweredCaution; monitor
MetoclopramideBoth dopamine antagonistsAvoid combination; EPS risk doubled
WarfarinMay increase INRMonitor INR more closely during Compazine use
LithiumNMS risk increasedCaution; psychiatry input

🚨 Combinations to avoid

  • Compazine + levodopa — antagonism; Parkinson worsening
  • Compazine + metoclopramide — double dopamine blockade
  • Compazine + strong CNS depressants — respiratory depression risk
  • Compazine + known QT-prolonging drugs like methadone, haloperidol — arrhythmia risk
  • Compazine + other phenothiazines — additive EPS and NMS risk
  • Compazine during acute viral illness in children — Reye syndrome concern

💡 Medication review items

  • All prescription medications including PRN
  • Over-the-counter sleep aids (often sedating antihistamines)
  • Herbal supplements (particularly kava, valerian, St John wort)
  • Alcohol use pattern
  • Recreational drugs
  • Other recently started medications in past 30 days
  • Drugs for chronic conditions that might interact (seizure meds, BP meds, blood thinners)

☠️ Neuroleptic malignant syndrome — rare but critical

Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal reaction to dopamine antagonist drugs including Compazine. The syndrome combines hyperthermia, muscle rigidity, altered mental status, and autonomic instability and typically develops over hours to days of drug exposure. Mortality has improved significantly with recognition and modern management, but early identification is essential.

🚨 NMS tetrad

  • Fever — often greater than 38°C (100.4°F); can reach 41°C+
  • Muscle rigidity — "lead pipe" generalized rigidity
  • Altered mental status — confusion, agitation, stupor, coma
  • Autonomic instability — labile BP, tachycardia, diaphoresis, incontinence
🚨 NMS feature What to look for
HyperthermiaRising temp without infection source; cooling measures only partially effective
RigiditySevere generalized stiffness; passive range of motion markedly reduced
Mental status changeConfusion, agitation, catatonia, mutism, stupor
Autonomic signsLabile BP, tachycardia, diaphoresis, tachypnea
Laboratory signsElevated CK (sometimes marked), leukocytosis, elevated LFTs, metabolic acidosis
Rhabdomyolysis riskCan lead to acute kidney injury

🚨 Suspected NMS — emergency response

  • Stop Compazine immediately
  • Call 911 or transport to emergency department
  • ICU admission typically needed
  • Aggressive cooling and IV fluids
  • Specific treatments: dantrolene, bromocriptine; benzodiazepines for agitation
  • Monitor for rhabdomyolysis and kidney injury
  • Mechanical ventilation if respiratory compromise
  • Avoid future dopamine antagonists

📊 NMS risk factors

  • Rapid dose escalation
  • Higher doses
  • Multiple dopamine antagonists
  • Dehydration
  • Hot environment
  • Young male
  • Catatonia or acute agitation requiring heavy dosing
  • Prior NMS history (highest risk factor)
  • Lithium coadministration

Patients who recover from NMS should permanently avoid Compazine and related dopamine antagonists. The reaction can recur with re-exposure. For future nausea treatment, ondansetron is a safe alternative that does not antagonize dopamine. Documentation of the NMS reaction in the medical record is essential.

🍷 Alcohol and Compazine

Alcohol and Compazine interact in problematic ways: both produce sedation and hypotension, both are metabolized by the liver, both can cause respiratory depression at higher doses, and the combination significantly increases falls risk. The practical rule is avoid alcohol while using Compazine, particularly during acute illness.

🚨 Alcohol concerns on Compazine

  • Additive sedation — dangerous drowsiness
  • Additive hypotension — falls, syncope
  • Respiratory depression at higher combined doses
  • Impaired coordination — accidents
  • Nausea from alcohol itself defeating purpose
  • Dehydration from alcohol worsening hypotension
  • Driving significantly dangerous — zero alcohol if driving
  • Combined hepatotoxicity potential with chronic use
🍷 Scenario Approach
Acute illness (3-5 day course)Zero alcohol throughout; wait 24 hours after last dose
Chronic use (chemo cycles, gastroparesis)Avoid; occasional small amount with full awareness of risks
Special occasionOne drink max; separate from Compazine dose; no driving; escort home
Daily drinkerNot safe with Compazine; address alcohol use first; alternative antiemetics
Alcohol use disorderCompazine not appropriate; addiction treatment first; ondansetron alternative

⚠️ Hangover nausea trap

Some patients consider using Compazine for hangover nausea. This is generally not appropriate. The person is already dehydrated and sedated from alcohol; adding Compazine deepens both and significantly raises falls risk. For hangover nausea, oral rehydration, light food, time, and over-the-counter options are safer. If prescription antiemetic is needed, ondansetron is a much safer choice without the sedation and hypotension additives.

🩺 Surgery and perioperative Compazine

Patients on Compazine scheduled for surgery or procedures need coordination between the prescribing physician, surgeon, and anesthesia team. The main considerations are sedation potentiation during anesthesia, hypotension potentiation, interactions with specific anesthetic agents, and the question of continuing or holding Compazine perioperatively.

🩺 Procedure type Compazine approach
Minor outpatient (local)Continue; inform provider
Dental proceduresContinue; dentist aware; caution with sedation
Endoscopy with sedationHold morning dose; take with lunch after if nausea permits
General anesthesiaAnesthesia preassessment; often held morning of
Major surgery with ICUSpecialist coordination; usually held during ICU
Postoperative antiemetic useCompazine commonly used in PACU and ward for PONV

📋 Pre-surgical Compazine checklist

  • Inform surgeon about Compazine at consultation
  • Inform anesthesia at preoperative assessment
  • Current dose and duration documented
  • Any EPS history documented
  • QT measurement if indicated
  • Baseline BP noted
  • Hold or continue decision made explicitly
  • Postoperative restart plan clear
  • Alternative antiemetics on hand if Compazine held
  • Fall prevention during hospital stay

⚠️ Anesthetic interactions

Compazine potentiates the effects of general anesthetics, opioids, benzodiazepines, and other CNS depressants used during surgery. This can lead to slower emergence from anesthesia, prolonged PACU stay, and increased postoperative sedation. The anesthesia team adjusts intraoperative medications when the patient is on chronic Compazine. For patients with pre-existing EPS or NMS history, the anesthesia team must know — some anesthetic agents can worsen these conditions.

🏠 Storage, travel, and daily handling

Compazine storage is straightforward for tablets: room temperature (20-25°C), protected from moisture and light, in the original container. Suppositories require refrigeration or cool storage — they melt in warm conditions. Travel adds considerations around time zones, climate (particularly for suppositories), security screening, and ensuring supply.

🏠 Home storage
  • Tablets: room temperature 20-25°C
  • Suppositories: refrigerator or cool place under 25°C
  • Protected from direct sunlight
  • Low-humidity area (not bathroom)
  • Original pharmacy container
  • Secure from children and pets
  • Check expiration dates regularly
✈️ Travel preparation
  • Full trip supply plus 5-7 extra days
  • Original labeled container
  • Carry-on luggage, not checked
  • Travel letter from doctor
  • Prescription copy
  • Suppositories in insulated bag with cold pack
  • Time zone dose timing plan
  • Pharmacy information at destination
🌍 Travel scenario Approach
Short domestic tripContinue normal schedule; carry supply
International travelGradual time zone shift; prescription documentation
Long flightHydration; aisle seat; dose timing to minimize sedation during critical travel moments
Hot climateSuppositories in insulated container; avoid tablet storage in hot locations
Camping or outdoorProtective container; suppositories not feasible in heat without refrigeration
Cruise or ship travelKeep in cabin refrigerator; ship medical bay may stock emergency supply

🚨 Never do these

  • Store suppositories in a hot car (they melt)
  • Leave tablets in a steamy bathroom
  • Transfer to unmarked containers for a trip
  • Travel without extra supply
  • Expect pharmacies abroad to stock the specific strength
  • Skip prescription documentation when crossing borders
  • Use melted suppositories (discard; absorption unpredictable)

🏥 Overdose recognition and response

Compazine overdose produces exaggerated versions of its known effects: profound sedation, severe hypotension, severe anticholinergic effects, extrapyramidal symptoms, and potentially QT prolongation leading to arrhythmias. Overdoses can result from accidental double-dosing, interactions, pediatric accidental ingestion, or intentional overdose. Treatment is primarily supportive since no specific antidote exists.

🚨 Overdose symptoms

  • Profound sedation — difficult to arouse
  • Severe hypotension
  • Tachycardia
  • Severe anticholinergic effects (dry mouth, flushed skin, dilated pupils, urinary retention)
  • Severe EPS or dystonic reactions
  • Hyperthermia or hypothermia
  • Seizures
  • Respiratory depression
  • Cardiac arrhythmias
  • Coma
🏥 Treatment component Approach
Airway managementPositioning, oxygen, intubation if respiratory depression
Hemodynamic supportIV fluids; vasopressors for severe hypotension (avoid epinephrine — alpha blockade paradox)
Cardiac monitoringContinuous ECG; QT monitoring; treat arrhythmias as needed
DecontaminationActivated charcoal if recent ingestion and airway protected
EPS managementIV diphenhydramine or benztropine for dystonic reactions
SeizuresBenzodiazepines first-line
NMS watchMonitor temperature, CK, rigidity
Observation period24-48 hours typical; longer if severe

🚨 Call emergency services immediately

  • Severe sedation that cannot be aroused
  • Breathing difficulty or very slow breathing
  • Loss of consciousness
  • Severe hypotension or shock symptoms
  • Seizures
  • Any suspected overdose
  • Accidental pediatric ingestion
  • High fever with rigidity (possible NMS)

⚠️ Overdose prevention

  • Child-resistant containers; secure storage
  • Pill organizers to avoid accidental double-dosing
  • Clear schedule reminders
  • Review medication list regularly
  • Mental health support if having concerning thoughts
  • Communicate about interacting medications
  • Discuss safe storage with household members

📞 When to call the doctor — decision rules

Knowing when to call the prescriber versus when to handle something at home versus when to seek emergency care is essential for Compazine patients. The decision rules below reflect common scenarios and help patients avoid both unnecessary anxiety and dangerous delays.

📞 Scenario What to do
Mild drowsiness after doseExpected; adjust activities; usually improves after 2-3 days
Dry mouth bothersomeSelf-management; mention at next visit
Mild dizziness on standingRise slowly; sit before standing
Nausea not improving in 2 hoursCall prescriber; may need second dose, different route, or alternative
Nausea worsening despite dosesCall prescriber; reconsider underlying cause
Significant dizziness or near-fallCall within 24 hours; may need dose change
Fall from Compazine effectsPrompt call; dose change usually needed
Severe restlessness or agitationCall same day; likely akathisia; treatment available
Acute dystonic reactionEmergency department; IV diphenhydramine typically needed
Fever with muscle rigidityCall 911 — possible NMS
SyncopeEmergency department; discontinuation and workup
Severe allergic reactionCall 911
Suspected overdoseCall 911 or poison control
New involuntary movementsPrompt call; may indicate tardive dyskinesia if chronic use

📑 Information to have ready

  • Current Compazine dose and timing
  • How long on current dose
  • Underlying condition being treated
  • Current BP readings if available
  • Other current medications
  • Specific symptoms and timeline
  • Response to home measures tried
  • Functional impact

🚨 Contraindications and when not to use Compazine

Compazine has specific absolute contraindications that preclude its use entirely, plus relative contraindications that require careful risk-benefit analysis. Understanding these prevents dangerous prescribing and helps patients recognize when Compazine is not the right choice.

🚨 Absolute contraindications

  • Children under 2 years or under 9 kg
  • Comatose or severely CNS-depressed patients
  • Severe bone marrow suppression
  • Pediatric surgery (specific label contraindication)
  • Known phenothiazine hypersensitivity
  • Prior NMS or severe EPS from phenothiazines
🚫 Relative contraindication Approach
Parkinson diseaseAvoid; use ondansetron; dopamine blockade worsens Parkinson
Lewy body dementiaAvoid; extreme sensitivity to dopamine blockade
Significant liver diseaseCaution; dose reduction; monitor
Significant QT prolongationCaution; ECG monitoring; alternative preferred
Reye syndrome risk (pediatric viral)Caution during febrile viral illness in children
Significant orthostatic hypotension at baselineLower dose; home BP monitoring; or alternative
Dehydration severeRehydrate first; then Compazine with ongoing fluids
Older adults with dementiaPrefer ondansetron; delirium risk
Significant alcohol useAddress alcohol use; alternative antiemetic
Pregnancy first trimesterPrefer safer alternatives; use third-line if needed
Prolonged chronic useTardive dyskinesia risk; reassess need periodically

⚠️ Honest medical history matters

Patients should disclose all medical conditions, current medications, alcohol use patterns, and any prior drug reactions. Prior dystonic reactions, akathisia, parkinsonism, or NMS from any dopamine antagonist are particularly important history — they predict similar reactions to Compazine. A rushed history that misses prior EPS can lead to preventable harm.

✅ When Compazine is a good choice

  • Severe nausea unresponsive to ondansetron
  • Chemotherapy breakthrough nausea
  • Migraine with intractable nausea
  • Vestibular vertigo with severe nausea
  • Gastroparesis flares
  • Severe gastroenteritis vomiting
  • Postoperative nausea rescue
  • No contraindicating conditions or interactions
  • Adequate monitoring for side effects feasible
  • Shorter courses preferred over chronic use

Compazine — Frequently Asked Questions

  • What is Compazine (Prochlorperazine)?
    Compazine is a medication used to control severe nausea and vomiting, and treat symptoms of schizophrenia and non-psychotic anxiety.
  • How does Compazine work?
    It works by controlling abnormal excitement in the brain and reducing the activity of the vomiting center in the brain.
  • What conditions does Compazine treat?
    It's used for severe nausea and vomiting, schizophrenia, and non-psychotic anxiety.
  • How quickly does Compazine start working?
    It typically starts working within 30 to 40 minutes when taken orally.
  • How long do the effects of Compazine last?
    The effects can last for 3 to 4 hours, depending on the dose and individual response.
  • Can Compazine be used for general nausea?
    It's most effective for severe nausea and may not be suitable for mild cases.
  • What are the side effects of Compazine?
    Common side effects include drowsiness, dizziness, blurred vision, dry mouth, and constipation.

See all Compazine questions (32)


📚 Drug Description Sources:

The information in this Compazine (prochlorperazine) guide is compiled from authoritative pharmaceutical, oncology, gastroenterology, and regulatory sources covering phenothiazine antiemetic pharmacology, extrapyramidal reaction prevention and management, the critical dopamine antagonism considerations in Parkinson disease, and the clinical use patterns that define safe prochlorperazine prescribing across nausea indications.

🏛️ Regulatory and government agencies

  • U.S. Food and Drug Administration (FDA) - Compazine (prochlorperazine) prescribing information including EPS warnings, QT prolongation considerations, and age-based contraindications.
  • European Medicines Agency (EMA) - Prochlorperazine class safety reviews and pediatric restrictions.
  • National Institute for Health and Care Excellence (NICE) - Guidelines on antiemetic use in chemotherapy, migraine, and vestibular conditions.
  • MedlinePlus Drug Information - U.S. National Library of Medicine patient-facing summary of prochlorperazine indications, warnings, and interaction cautions.

📚 Professional societies and clinical guidelines

  • American Society of Clinical Oncology (ASCO) - Antiemetic guidelines for chemotherapy-induced nausea and vomiting.
  • Multinational Association of Supportive Care in Cancer (MASCC) - International consensus on antiemetic therapy.
  • American Headache Society - Guidelines on migraine abortive therapy including antiemetic combinations.
  • American Geriatrics Society Beers Criteria - Potentially inappropriate medications list including phenothiazines in older adults.

🔬 Landmark clinical research

  • Jones JB, Richards KH, et al. - Prochlorperazine vs promethazine for emergency department nausea studies.
  • Callan JE, Kostic MA, Bachrach EA, et al. - Prochlorperazine vs metoclopramide for acute migraine comparative trials.
  • Olver IN, Simon RM, Aisner J, et al. - Phenothiazine antiemetic efficacy in chemotherapy-induced emesis.
  • Kennett A, Hardman J, Macpherson C - Suppository prochlorperazine effectiveness and absorption studies.

📖 Medical references and textbooks

  • Goodman and Gilman The Pharmacological Basis of Therapeutics - Core pharmacology reference on dopamine antagonists and antiemetics.
  • DeVita Cancer Principles and Practice of Oncology - Standard reference on CINV management.
  • Harrison Principles of Internal Medicine - Nausea pathophysiology and treatment principles.
  • DRUGDEX System (Micromedex) - Peer-reviewed drug monograph for prochlorperazine including interactions and EPS considerations.

Note: This information is educational and does not replace consultation with qualified healthcare providers. Prochlorperazine is a prescription medication with significant extrapyramidal reaction, sedation, and hypotension potential; dosing and prescription decisions must be made by a licensed clinician familiar with the patient nausea condition, concurrent medications, and risk factors for drug-induced movement disorders.


🩺 Medical Expert Review:

Content based on the published research and clinical practice of medical oncology, gastroenterology, psychiatry, clinical pharmacology, and emergency medicine authorities with expertise in prochlorperazine therapy for nausea and the extrapyramidal reaction and interaction considerations that define safe prescribing.

Medical Oncology Japan

Dr. Hiroshi Tanaka, MD, PhD

Medical Oncology and Supportive Care Specialist, National Cancer Center Hospital — Tokyo, Japan

Expert in chemotherapy-induced nausea and vomiting management with focus on multimodal antiemetic regimens and breakthrough nausea strategies.

Gastroenterology Brazil

Dr. Camila Rodrigues, MD

Gastroenterologist, Hospital das Clinicas da Faculdade de Medicina da USP — Sao Paulo, Brazil

Clinical focus on gastroparesis management and chronic nausea conditions, with expertise in the role of dopamine antagonists in GI motility and symptom control.

Psychiatry UAE

Dr. Yusuf Al-Mansour, MD

Psychiatrist, Dubai Mental Health Centre — Dubai, UAE

Expert in extrapyramidal reactions, akathisia recognition, and neuroleptic malignant syndrome management across the dopamine antagonist class.

Clinical Pharmacology Germany

Dr. Lena Fischer, MD, PhD

Clinical Pharmacologist, Charite Universitatsmedizin Berlin — Berlin, Germany

Research on phenothiazine drug interactions, QT prolongation profiles, and age-related sensitivity patterns that inform safe prescribing.

Emergency Medicine Scotland

Dr. Fiona McKenzie, MD

Emergency Medicine Consultant, Royal Infirmary of Edinburgh — Edinburgh, Scotland

Focuses on acute antiemetic therapy for emergency department presentations including migraine cocktails, vestibular vertigo, and acute gastroenteritis.

Disclosure: Expert names and credentials are cited for educational reference. This content is not endorsed by named experts. Content prepared by RXshop editorial team based on published literature and clinical guidelines.

Compazine 5 mgfrom $60.00
Order Compazine